Ground Truths β’ 10148 implied HN points β’ 14 Feb 25
- There are now 6 different nasal vaccines in clinical trials in the US aimed at preventing COVID-19 and blocking its transmission. These vaccines are promising because they might work better than traditional shots.
- Two major challenges facing these new vaccines are the low current levels of the virus, which make it harder to gather data from trials, and the uncertainty about ongoing government support for these projects.
- Successful nasal vaccines could provide a convenient way to protect people from COVID-19, but it will take time to find out if they really work well in humans.